The three-decade-old international cutpoint for diagnosing children and adolescents with an enlarged heart misclassifies normal heart size as cardiac damage in adolescents, a paper published in the American Journal of Physiology-Heart and Circulatory Physiology concludes
March 13, 2023
Researchers Suggest Novel Cutpoints for Diagnosing Cardiac Hypertrophy in Adolescents and Young Adults
March 13, 2023 —  An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage…
Read More
Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and services
March 13, 2023
Large Real-World Evidence Analysis of Zio XT
March 13, 2023 —  iRhythm Technologies, Inc., a leading digital health company focused on creating trusted solutions…
Read More
Leadership of the American College of Cardiology (ACC), acknowledged recipients of distinguished awards, recognized global partners and reinforced the value of collaboration during the 72nd Convocation held at the conclusion of its ACC.23 Together with the World Congress, ACC.23/WCC held March 4-6 in New Orleans, LA.
March 12, 2023
American College of Cardiology (ACC) Champions Distinguished Awards Winners at ACC.23/WCC Convocation
March 12, 2023 — As part of its ongoing news coverage of ACC23, the DAIC/dicardiology.com editorial team has condensed…
Read More
The first evidence that exceeding the World Health Organization (WHO) ozone limit is associated with substantial increases in hospital admissions for heart attack, heart failure and stroke
March 11, 2023
Ozone Pollution is Linked with Increased Hospitalizations for Cardiovascular Disease
March 10, 2023 — The first evidence that exceeding the World Health Organization (WHO) ozone limit is associated with…
Read More
Researchers found evidence of heart muscle inflammation in a small number of patients with acute myocarditis after COVID-19 vaccination, but not in patients without acute myocarditis
March 10, 2023
Study Examines Heart Inflammation after COVID Vaccine
March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute…
Read More
nari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary embolism (“PE”).
March 10, 2023
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System
March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of…
Read More
A large UW Medicine-Kaiser Permanente study finds modestly increased risk, with a stronger link seen among younger, healthier people.
March 09, 2023
Incident Atrial Fibrillation Appears to Heighten Dementia Risk
March 9, 2023 — People with a recent diagnosis of atrial fibrillation (AF), the most common irregular heart rhythm,…
Read More
Researchers Suggest Novel Cutpoints for Diagnosing Cardiac Hypertrophy in Adolescents and Young Adults
March 09, 2023
Researchers Suggest Novel Cutpoints for Diagnosing Cardiac Hypertrophy in Adolescents and Young Adults
March 9, 2023 — An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage…
Read More
C. Noel Bairey Merz, MD, Director of the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute, received the distinguished achievement of Master of the ACC (MACC) on March 6 during Annual Scientific Session
March 09, 2023
American College of Cardiology Honors Women’s Heart Disease Pioneer
March 9, 2023 — C. Noel Bairey Merz, MD, FACC, professor of cardiology and the director of the Barbra Streisand Women’s…
Read More
Use of an antihypertensive to lower blood pressure in obese patients was found effective, according to Target-HTN Trial results presented during the 2023 American College of Cardiology Scientific Session.
March 09, 2023
Data from Target-HTN Trial Released at ACC23 Supports Use of Antihypertensive to Reduce Blood Pressure in Obese Patients
March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated…
Read More
Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in women, according to a review published today in European Heart Journal – Quality of Care and Clinical Outcomes, a journal of the European Society of Cardiology (ESC)
March 08, 2023
Clogged Leg Arteries Underdiagnosed and Undertreated in Women
March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in…
Read More
Study will evaluate THERMOCOOL SMARTTOUCH SF Dual Energy Catheter’s potential to enable safer and simpler procedures with the ability to deliver both radiofrequency and pulsed field ablation
March 08, 2023
Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial
March 8, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
B. Hadley Wilson, MD, FACC, is the new president of the American College of Cardiology.
March 08, 2023
Dr. B. Hadley Wilson is new American College of Cardiology President
March 8, 2023 — B. Hadley Wilson, MD, FACC, is the new president of the American College of Cardiology. Today marks the…
Read More
A study to better understand the association between Lipoprotein(a), Lp(a) levels and artherosclerotic cardiovascular disease (ASCVD) in an underrepresented population has been announced by Amgen, which will be working with the Association of Black Cardiologists and the Morehouse School of Medicine on the African American Heart Study.
March 08, 2023
African American Heart Study Announced by Amgen, in Collaboration with Association of Black Cardiologists and Morehouse School of Medicine
March 8, 2023 — A unique community-based partnership, the African American Heart Study, will be conducted to measure…
Read More
Wearable sensor could be cheaper, less invasive way to reduce hospital readmissions
March 07, 2023
Stick-on Device Provides Early Warning of Heart Failure Complications
March 7, 2023 — People with heart failure were 38% less likely to be readmitted to the hospital for heart failure…
Read More
Partho P. Sengupta, MD, professor of cardiology at Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey
March 07, 2023
Bracelet Sensor Assesses Troponin Levels to Aid Heart Attack Diagnosis
March 7, 2023 — An experimental wrist-worn device was found to predict troponin-I and obstructed arteries with 90%…
Read More
Analysis finds most athletes had no cardiac events over seven years, underscoring importance of shared decision-making
March 07, 2023
Cardiac Risks Appear Low for Elite Athletes with Diagnosed, Treated Genetic Heart Disease
March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no…
Read More
Kelly Chin, MD, professor of medicine and director of the pulmonary hypertension program at UT Southwestern Medical Center in Dallas
March 06, 2023
Fixed-Dose Combination Pill Outperforms Monotherapy for Pulmonary Hypertension
March 6, 2023 — Patients with pulmonary arterial hypertension (high blood pressure in the arteries that supply the…
Read More
Neha J. Pagidipati, MD, MPH, associate professor of medicine in cardiology at Duke University School of Medicine and Duke Clinical Research Institute
March 06, 2023
Multifaceted Strategy Boosts Preventive Care for Diabetes, Heart Disease
March 6, 2023 — A multifaceted intervention to improve prescribing practices increased the likelihood that patients…
Read More
Atul Verma, MD, head of cardiology at McGill University Health Centre in Montreal, Canada
March 06, 2023
New Ablation Technology Found Safe, Effective for Atrial Fibrillation
March 6, 2023 — A new ablation technology known as pulsed field ablation was successful at eliminating episodes of…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now